Julie Mazenq
Julie Mazenq is an expert in Pediatrics at Hôpitaux universitaires de Marseille (France). Julie Mazenq has authored 53 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 3 of them ongoing. SLR score: 246 (community average: 125). How the SLR is computed.
LeadR Profile
Pediatrics
Subspecialties: Pulmonology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 53
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Bronchial Hyperresponsiveness in Pediatric Non-Cystic Fibrosis Bronchiectasis. PMID 42770383 — bronchodilator agents, lung, fibrosis, signs and symptoms, cystic fibrosis, prevalence, therapeutics, pediatrics, asthma, vital capacity, bronchiectasis, child | Pediatr Pulmonol | 2026 | 0 |
| Home CPAP/NIV in pediatric patients: which disorders? PMID 42202500 — sleep apnea, obstructive, sleep apnea syndromes, child, sleep wake disorders | Sleep Med | 2026 | 0 |
| An Ex Vivo Model of Post Infectious Bronchiolitis Obliterans in Children Using Reconstituted Human Bronchial Epithelium. PMID 42194084 — cells, mucins, epithelial cells, alarmins, biopsy, bronchiolitis obliterans, epithelium, bronchiolitis, antiviral agents, child | Biomolecules | 2026 | 0 |
| Unanswered questions regarding the AIR strategy in children. PMID 41905360 — air, child | Lancet Top journal | 2026 | 0 |
| Open randomised withdrawal study of long-term azithromycin in paediatric non-cystic fibrosis bronchiectasis. PMID 41878278 — fibrosis, cystic fibrosis, azithromycin, bronchiectasis | ERJ Open Res | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to investigate the efficacy and safety of tezepelumab compared with placebo in children 5 to 12 years old with severe asthma 2022-502984-39-00 — safety, respiration, therapeutics, asthma, child | Phase 3 | Not yet recruiting | 2023 |
| Efficacy of methylprednisolone pulses in neuroendocrine cells hyperplasia of infancy an early phase study (CORTICONEHI) 2023-508132-65-00 — cells, methylprednisolone, neuroendocrine cells, hyperplasia, pulse | Phase 2 | Recruiting | 2025 |
| Bronchial Epithelium of Children With Post infectious Bronchiolitis Obliterans NCT06140901 — pilot projects, pilots, respiratory tract infections, diagnosis, bronchiolitis obliterans, therapeutics, epithelium, bronchiolitis, infections, child | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map